Evidence map›Paper›PMID 37933309›Full record

ArticleCase reports in oncology

Transarterial Selective Internal Radiation Therapy with Yttrium-90 for Liver Metastatic Urothelial Carcinoma of the Ureter as a Bridging Therapy to Immunotherapy: A Case Report with a 10-Year Follow-Up.

Bruno Pagnin Schmid, Marcela Juliano Silva Cunha, Leonardo Guedes Moreira Valle, Francisco Leonardo Galastri, Breno Boueri Affonso, Priscila Mina Falsarella, Rafael Aliosha Kaliks Guendelmann, Rodrigo Gobbo Garcia, Felipe Nasser

Open access · goldAbstract readCase Reports
In one paragraph

Article in Case reports in oncology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Bruno Pagnin SchmidDepartment of Interventional Radiology, Hospital Israelita Albert Einstein, Sao Paulo, Brazil.
Marcela Juliano Silva CunhaDepartment of Interventional Radiology, Hospital Israelita Albert Einstein, Sao Paulo, Brazil.
Leonardo Guedes Moreira ValleDepartment of Interventional Radiology, Hospital Israelita Albert Einstein, Sao Paulo, Brazil.
Francisco Leonardo GalastriDepartment of Interventional Radiology, Hospital Israelita Albert Einstein, Sao Paulo, Brazil.
Breno Boueri AffonsoDepartment of Interventional Radiology, Hospital Israelita Albert Einstein, Sao Paulo, Brazil.
Priscila Mina FalsarellaDepartment of Interventional Radiology, Hospital Israelita Albert Einstein, Sao Paulo, Brazil.
Rafael Aliosha Kaliks GuendelmannDepartment of Oncology, Hospital Israelita Albert Einstein, Sao Paulo, Brazil.
Rodrigo Gobbo GarciaDepartment of Interventional Radiology, Hospital Israelita Albert Einstein, Sao Paulo, Brazil.
Felipe NasserDepartment of Interventional Radiology, Hospital Israelita Albert Einstein, Sao Paulo, Brazil.
Hospital Israelita Albert Einstein · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary transitional cell carcinoma of the ureter is a rare type of cancer with metastasis presented in approximately 25% at diagnosis. Due to its rarity and poor prognosis, the management of this neoplasm is still controversial, and the development of new therapies is of uttermost importance. Herein, we describe a case of a 54-year-old patient diagnosed with transitional cell carcinoma of the left ureter submitted to left nephroureterectomy (pT3N2M0) and methotrexate, vinblastine, doxorubicin, and cisplatin adjuvant chemotherapy. A single liver metastasis was detected and combination chemotherapy with gemcitabine and carboplatin was initiated along with stereotactic body radiation therapy. Despite these 2 previous chemotherapy regimens, the patient presented disease progression and transarterial selective internal radiation therapy (SIRT) with yttrium-90 was indicated. This locoregional treatment was performed with the administration of 1.2 GBq yttrium-90 resin microspheres (SIR-Spheres

Indexed as

CarcinomaCase reportEmbolizationImmunotherapyLiver neoplasmsTherapeutic synergismTransitional cellYttrium radioisotopes

Identifiers

PMID37933309
PMCPMC10625822
OpenAlexW4387543673

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.